Velsera
Solutions for Clinical Genomics Implementation, Reporting, and Multimodal Data Analysis
Boston, United States · Founded 2023
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2023
- Business Model
- B2B
- Website
- velsera.com
- Last Round
- Private EquityJan 2023
- Rounds
- 1
About
AI-enhanced software and services accelerating precision medicine discovery and delivery.
Summary
Velsera is a Biotech company based in Boston, United States, founded in 2023. Its most recent funding was a Private Equity round in Jan 2023. Investors include Summa Group.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/velsera"><img src="https://indexed.vc/api/badge/company/velsera" alt="Velsera on Indexed.vc" width="260" height="76" /></a>